share_log

Morgan Stanley Maintains Equal-Weight on Ascendis Pharma, Maintains $116 Price Target

Moomoo 24/7 ·  Apr 22 13:15

Morgan Stanley analyst Vikram Purohit maintains Ascendis Pharma (NASDAQ:ASND) with a Equal-Weight and maintains $116 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment